These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 16252065

  • 1. Synergistic effect of alpha-dihydroergocryptine and L-dopa or dopamine on dopaminergic neurons in primary culture.
    Gille G, Radad K, Reichmann H, Rausch WD.
    J Neural Transm (Vienna); 2006 Sep; 113(9):1107-18. PubMed ID: 16252065
    [Abstract] [Full Text] [Related]

  • 2. Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors.
    Takashima H, Tsujihata M, Kishikawa M, Freed WJ.
    Exp Neurol; 1999 Sep; 159(1):98-104. PubMed ID: 10486178
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of L-DOPA on nigral dopamine neurons and local field potential: comparison with apomorphine and muscimol.
    Xu D, Karain B, Brantley E, Shi WX.
    J Pharmacol Exp Ther; 2011 May; 337(2):533-9. PubMed ID: 21330359
    [Abstract] [Full Text] [Related]

  • 6. Dual effects of L-DOPA on nigral dopaminergic neurons.
    Guatteo E, Yee A, McKearney J, Cucchiaroni ML, Armogida M, Berretta N, Mercuri NB, Lipski J.
    Exp Neurol; 2013 Sep; 247():582-94. PubMed ID: 23481547
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effects of L-3,4-dihydroxyphenylalanine and dopamine agonists on dopamine neurons in the progressive hemiparkinsonian rat models.
    Jeon MY, Lee WY, Kang HY, Chung EJ.
    Neurol Res; 2007 Apr; 29(3):289-95. PubMed ID: 17509229
    [Abstract] [Full Text] [Related]

  • 11. Nigrostriatal dopaminergic neurons remain undamaged in rats given high doses of L-DOPA and carbidopa chronically.
    Perry TL, Yong VW, Ito M, Foulks JG, Wall RA, Godin DV, Clavier RM.
    J Neurochem; 1984 Oct; 43(4):990-3. PubMed ID: 6147392
    [Abstract] [Full Text] [Related]

  • 12. Protective effects of L-dopa and carbidopa combined treatments on human catecholaminergic cells.
    Colamartino M, Padua L, Meneghini C, Leone S, Cornetta T, Testa A, Cozzi R.
    DNA Cell Biol; 2012 Nov; 31(11):1572-9. PubMed ID: 23020119
    [Abstract] [Full Text] [Related]

  • 13. L-DOPA-induced increase in TH-immunoreactive striatal neurons in parkinsonian mice: insights into regulation and function.
    Espadas I, Darmopil S, Vergaño-Vera E, Ortiz O, Oliva I, Vicario-Abejón C, Martín ED, Moratalla R.
    Neurobiol Dis; 2012 Dec; 48(3):271-81. PubMed ID: 22820144
    [Abstract] [Full Text] [Related]

  • 14. Dopamine and L-dopa: inhibition of thyrotropin-stimulated thyroidal thyroxine release.
    Maayan ML, Sellitto RV, Volpert EM.
    Endocrinology; 1986 Feb; 118(2):632-6. PubMed ID: 2867890
    [Abstract] [Full Text] [Related]

  • 15. Metabolic inhibition enhances selective toxicity of L-DOPA toward mesencephalic dopamine neurons in vitro.
    Nakao N, Nakai K, Itakura T.
    Brain Res; 1997 Nov 28; 777(1-2):202-9. PubMed ID: 9449429
    [Abstract] [Full Text] [Related]

  • 16. Comparison of neurotoxicity following repeated administration of l-dopa, d-dopa and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donors.
    Alexander T, Sortwell CE, Sladek CD, Roth RH, Steece-Collier K.
    Cell Transplant; 1997 Nov 28; 6(3):309-15. PubMed ID: 9171163
    [Abstract] [Full Text] [Related]

  • 17. Dual motor response to l-dopa and nociceptin/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: Paradoxical inhibition is relieved by D(2)/D(3) receptor blockade.
    Viaro R, Marti M, Morari M.
    Exp Neurol; 2010 Jun 28; 223(2):473-84. PubMed ID: 20122926
    [Abstract] [Full Text] [Related]

  • 18. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
    Van De Witte SV, Groenewegen HJ, Voorn P.
    Synapse; 2002 Jan 28; 43(1):1-11. PubMed ID: 11746728
    [Abstract] [Full Text] [Related]

  • 19. Neurotrophic effects of L-DOPA in postnatal midbrain dopamine neuron/cortical astrocyte cocultures.
    Mena MA, Davila V, Sulzer D.
    J Neurochem; 1997 Oct 28; 69(4):1398-408. PubMed ID: 9326268
    [Abstract] [Full Text] [Related]

  • 20. Levodopa (L-DOPA) attenuates endoplasmic reticulum stress response and cell death signaling through DRD2 in SH-SY5Y neuronal cells under α-synuclein-induced toxicity.
    Song J, Kim BC, Nguyen DT, Samidurai M, Choi SM.
    Neuroscience; 2017 Sep 01; 358():336-348. PubMed ID: 28687316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.